Thus, it is not surprising to see that treatment of cancer cells with IL1β caused a concerted increase in EMT as well as in PD-L1 levels; the consistency in these trends was also visible upon withdrawal of the signal (Figure 3C). This evidence concerns the gene IL1B and cancer.